• Decision Support in High Definition

    Bio-IT World | A high-definition touch screen that fosters collaboration by enabling drug developers to manipulate molecules, much like Tom Cruise sifting through a crime scene in Steven Spielberg’s Minority Report, was the high point of Bryn Roberts’ keynote on novel decision support technologies at the 2011 Bio-IT World Conference.

     

    Jun 9, 2011

  • The Search for Answers

    Stephen Wolfram computes answers to never before asked questions. By Kevin Davies June 8, 2011 | “Wolfram|Alpha knows about lots of things,” said its creator, the British mathematical prodigy Stephen Wolfram, CEO of Wolfram Research and author of A New

    Jun 7, 2011

  • Oncologists Consider Genomic Treatments

    Wall Street Journal | Over the weekend at the American Society of Clinical Oncology meeting, researchers discussed using genomics to match drugs to the biological drivers of tumors in patients.

    Jun 5, 2011

  • Jackson Lab Shelves Florida Personalized Medicine Institute

    Sarasota Herald Tribune | The famous Jackson Laboratory in Maine is pulling out of a planned venture to build a personalized medicine institute in Sarasota County, Florida.  

    Jun 3, 2011

  • Rothberg's Ion Torrent Decodes 'Frankenstein Bacteria'

    Hartford Courant | "It really is a Frankenstein bacteria," says Jonathan Rothberg, founder of Ion Torrent, the Connecticut next-generation sequencing company that has decoded the hybrid E.coli bacterium that has caused fatalities in Germany.

    Jun 3, 2011

  • German Teams, BGI and Life Technologies Identify Deadly European E.coli Strain

    Bio-IT World | Two teams of German researchers, one collaborating with BGI-Shenzhen in China, the other with LIfe Technologies, have identified some of the key genes responsible for the unusual toxicity and resistance of this hybrid strain, which has already claimed 17 lives in Germany.  

    Jun 2, 2011

  • Biogen Idec's Next Steps

    Boston Globe | Since George Scangos took the lead at Biogen Idec, he has cut 13% of the company's gobal workforce, dumped more than a dozen drug development projects, and halted the company's move from Cambridge to Weston, Mass.

    May 30, 2011

  • RNA Editing Paper Draws Computational Criticism

    Nature | Computational biologists are pointing out flaws in the observations of authors of a Science paper published last week that claimed that RNA editing changes bases after transcription.

    May 25, 2011

  • The Most Innovative Countries--Who's On Top?

    Forbes | In 2009, Chinese researchers published more IT papers than US researchers--the first time China has passed the US. However in Biology and Medicine, the US still published far more papers than any other country, likely due to big pharma's presense and the clinical trial infrastructure.

    May 25, 2011

  • RNA Editing Much More Widespread than Imagined

    Nature | Results published in Science yesterday suggest that the DNA-RNA-protein workflow that forms the basis of biology may not be as straightforward as we thought.

    May 19, 2011

  • NVIDIA Unveils New Flagship GPU Processor

    Bio-IT World | The latest flagship GPU (graphics processing unit) processor from NVIDIA, the Tesla M2090, and a new GPU server from HP, demonstrate the growing potential of GPUs in life science applications. 

    May 17, 2011

  • Dean Charney Lures PacBio’s Schadt to Mount Sinai

    Bio-IT World |  Dennis Charney, Dean of the Mount Sinai School of Medicine (MSSM), says he went after Pacific Biosciences CSO Eric Schadt "big time" to head MSSM’s new Institute of Genomics and Multiscale Biology and the Department of Genetics.

    May 16, 2011

  • PacBio CSO Eric Schadt to Lead ‘Multiscale Institute’ at Mount Sinai

    Bio-IT World |  Pacific Biosciences has announced a bi-coastal partnership with Mt Sinai School of Medicine (MSSM) in New York City to create the Institute for Genomics and Multiscale Biology. The new institute will be lead by PacBio’s chief science officer Eric Schadt, who will nonetheless retain his position at PacBio.  

     

    May 16, 2011

  • The Newest of the Next Generation Sequencers

    Technology Review | The newest sequencing company, Noblegen, is developing a "simplified version" of nanopore sequencing, says the company, that will be able to sequence a genome every 30 seconds.

    May 15, 2011

  • Broad Institute, IBM, Among EMC’s Inaugural ‘Data Heroes’

    Bio-IT World | The IT group at the Broad Institute and the IBM team that developed the Watson supercomputer, are among the winners of EMC’s inaugural Data Hero Awards, announced this week at EMC World in Las Vegas.   

    May 11, 2011

  • Battelle Report Finds $800-Million Economic Impact of Human Genome Project

    Fast Company | The Human Genome Project has driven $796 billion in economic impact and generated $244 billion in total personal income, according to a new report from Battelle.  

    May 11, 2011

  • More Big Biotech Mergers On the Way

    Reuters | Major drugmakers need the growth potential of biotech now more than ever, says David Snow, even though drug executives and bankers are keeping quiet on big price tag mergers and acquisitions.

    May 10, 2011

  • DNA2.0 Offers Third-Party Genetic Constructs

    Bio-IT World | DNA2.0 will announced that it will offer third-party genetic constructs through the company’s groundbreaking gene assembly and design application, Gene Designer, tomorrow at PEGS 2011 in Boston.

    May 9, 2011

  • Illumina Announces $5,000 Genome Pricing

    Bio-IT World | Illumina is lowering the price for sequencing whole human genomes through its the Illumina Genome Network (IGN) to $5,000 per genome (for orders of ten samples or more) and just $4,000 for projects of 50 samples or more.  

    May 9, 2011

  • PacBio Shares Fall

    Motley Fool | PacBio shares fell 12% yesterday after commentary plugged Illumina and Life Technologies and hinted that GE and IBM may enter the market.

    May 3, 2011